Evidence map›Paper›PMID 40979996›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025

May Measurement Month 2022: an analysis of blood pressure screening results from Nigeria.

Ganiyu A Amusa, Kolawole W Wahab, Philip M Kolo, Augustine Odili, Akinyemi Aje, Henry Iheonye, James A Ogunmodede, Wemimo A Alaofin, Abiodun H Bello, Sani A Abubakar and 7 more

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Post-Coital Intracranial Haemorrhage: A Nigerian Regional Experience.Nigerian medical journal : journal of the Nigeria Medical Association
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ganiyu A AmusaDepartment of Medicine, University of Jos/Jos University Teaching Hospital, PMB 2076, Jos, Plateau State, Nigeria.
Kolawole W WahabDepartment of Medicine, University of Ilorin, PMB 1515, Ilorin 240001, Kwara State, Nigeria.
Philip M KoloDepartment of Medicine, University of Ilorin, PMB 1515, Ilorin 240001, Kwara State, Nigeria.
Augustine OdiliDepartment of Medicine, University of Abuja, PMB 117, Abuja, Federal Capital Territory, Nigeria.ORCID https://orcid.org/0000-0002-4564-1587
Akinyemi AjeDepartment of Medicine, University College Hospital, Queen Elizabeth Road, PMB 5017, Ibadan, Oyo State, Nigeria.
Henry IheonyeDepartment of Medicine, Federal Teaching Hospital, PMB 1001, Lokoja, Kogi State, Nigeria.
James A OgunmodedeDepartment of Medicine, University of Ilorin, PMB 1515, Ilorin 240001, Kwara State, Nigeria.
Wemimo A AlaofinDepartment of Medicine, University of Ilorin, PMB 1515, Ilorin 240001, Kwara State, Nigeria.
Abiodun H BelloDepartment of Medicine, University of Ilorin, PMB 1515, Ilorin 240001, Kwara State, Nigeria.
Sani A AbubakarDepartment of Medicine, Ahmadu Bello University, Shika, PMB 06, Zaria, Kaduna State, Nigeria.
Ernest NwazorDepartment of Medicine, Rivers State University, PMB 5039, Port Harcourt, Rivers State, Nigeria.
Yekeen AyoolaDepartment of Medicine, Federal Teaching Hospital, PMB 0037, Gombe, Gombe State, Nigeria.
Umezurike H OkaforDepartment of Medicine, Enugu State University Teaching Hospital, PMB 1030, Enugu, Enugu State, Nigeria.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.ORCID https://orcid.org/0000-0001-9709-7264
Gabriele KerrImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Ayodele B OmotosoDepartment of Medicine, University of Ilorin, PMB 1515, Ilorin 240001, Kwara State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The May Measurement Month (MMM) campaign was carried out in Nigeria in 2022 to raise awareness of high blood pressure (BP). Here, we report on the campaign's findings. Adults aged ≥18 years were recruited opportunistically at public and private areas, pharmacies, clinics, and hospitals across the six geopolitical zones of Nigeria. Three seated BP readings were taken for each participant, and a questionnaire on demographics, lifestyle factors, and comorbidities was completed. Hypertension was defined as a systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled hypertension was defined as being on antihypertensive medication with a BP < 140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 5798 were screened, with a mean age of 44.2 years, and 54.8% were female. Of all participants, 2330 (40.2%) had hypertension, of whom 1362 (58.5%) were aware, and 1241 (53.3%) were on antihypertensive medication. Of those on antihypertensive medication, 522 (42.1%) had controlled BP, and of all participants with hypertension, 22.4% had controlled BP. The MMM campaign in Nigeria identified significant numbers of participants with either untreated or inadequately treated hypertension. There is a poor awareness and unacceptably high burden of hypertension among the Nigerian population. Urgent actions are required to improve the awareness of hypertension and reduce its associated health burden in Nigeria.

Indexed as

Blood pressureControlHypertensionNigeriaScreeningTreatment

Identifiers

PMID40979996
PMCPMC12449229

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.